This indicates that zinc supplementation may mitigate the decline in HIF-1α expression in cells by enhancing its degradation through the proteasome pathway, thereby alleviating the adverse effects associated with HIF-1α during the later stages of DKD (Aschner et al., 2023; Nardinocchi et al., 2010). This evidence concerns the gene HIF1A and diabetic kidney disease.